179 related articles for article (PubMed ID: 26763342)
1. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
Hutton LMJ; Cave AJ; St-Jean R; Banh HL
J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
[TBL] [Abstract][Full Text] [Related]
2. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.
Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L
J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856
[TBL] [Abstract][Full Text] [Related]
3. Citalopram, QTc Prolongation, and Torsades de Pointes.
Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
[TBL] [Abstract][Full Text] [Related]
4. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of QT prolongation with serotonin reuptake inhibitors.
Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
[TBL] [Abstract][Full Text] [Related]
6. Drug monitoring of a case of citalopram overdosage.
Liotier J; Coudoré F
Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
[TBL] [Abstract][Full Text] [Related]
7. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of the cardiac toxicity of citalopram: part 1.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the risk of QT prolongation among SSRIs.
Funk KA; Bostwick JR
Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
[TBL] [Abstract][Full Text] [Related]
10. Citalopram and cardiac toxicity.
Cooke MJ; Waring WS
Eur J Clin Pharmacol; 2013 Apr; 69(4):755-60. PubMed ID: 22996077
[TBL] [Abstract][Full Text] [Related]
11. A question about the potential cardiac toxicity of escitalopram.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011
[TBL] [Abstract][Full Text] [Related]
12. Citalopram, escitalopram, and the QT interval.
Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
[No Abstract] [Full Text] [Related]
13. QTc interval prolongation associated with citalopram overdose: a case report and literature review.
Catalano G; Catalano MC; Epstein MA; Tsambiras PE
Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127
[TBL] [Abstract][Full Text] [Related]
14. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
van Haelst IM; van Klei WA; Doodeman HJ; Warnier MJ; De Bruin ML; Kalkman CJ; Egberts TC
J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
Beach SR; Kostis WJ; Celano CM; Januzzi JL; Ruskin JN; Noseworthy PA; Huffman JC
J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
[TBL] [Abstract][Full Text] [Related]
16. Citalopram induced torsade de pointes, a rare life threatening side effect.
Kanjanauthai S; Kanluen T; Chareonthaitawee P
Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
[TBL] [Abstract][Full Text] [Related]
17. [Citalopram and QT prolongation].
Alušík Š; Paluch Z
Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745
[TBL] [Abstract][Full Text] [Related]
18. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T
Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095
[TBL] [Abstract][Full Text] [Related]
19. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095
[No Abstract] [Full Text] [Related]
20. Citalopram (Celexa) and QT interval prolongation.
Med Lett Drugs Ther; 2012 Sep; 54(1398):71-2. PubMed ID: 22992488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
